Lactic Acidosis During and After Seizures
NCT01833247 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 12
Last updated 2017-05-05
Summary
This project looks at the time course of lactic acid rise (if any) after seizures. Salivary and capillary lactic acid are tested. This type of measurement may be useful in signalling the occurrence or recent history of a seizure.
Conditions
Sponsors & Collaborators
- lead OTHER
Principal Investigators
-
Robert S Fisher, MD, PhD · Stanford University Department of Neurology
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-07-31
- Primary Completion
- 2014-12-31
- Completion
- 2014-12-31
Countries
- United States
Study Locations
More Related Trials
-
Effect of the New Definition of Epilepsies of the ILAE of 2014 on the Diagnosis After the First Seizure
NCT06836687 ·Status: RECRUITING
-
LAMICTAL (Lamotrigine) For The Treatment Of Absence Seizures
NCT00144872 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy and Safety of Lacosamide as Adjunctive Therapy in Subjects ≥1 Month to <4 Years With Partial-onset Seizures
NCT02477839 ·Status: COMPLETED ·Phase: PHASE3
-
Intermittent Fasting in Refractory Epilepsy
NCT02311023 ·Status: TERMINATED ·Phase: PHASE2
-
Late-Onset Seizures: Trial of Vascular Risk Investigation and Treatment
NCT07116330 ·Status: RECRUITING
-
Open-Label Study to Assess Lacosamide Safety as Add-on Therapy for Primary Generalized Tonic-Clonic Seizures in Subjects With Epilepsy
NCT01118949 ·Status: COMPLETED ·Phase: PHASE2
-
Pharmacokinetics Study of Oral 2-Deoxy-D-Glucose (2DG) in Subjects With a Confirmed Diagnosis of Epilepsy
NCT05605301 ·Status: COMPLETED ·Phase: PHASE2
-
Value of Copeptin Assay in Children With Febrile Seizures at Sohag University Hospital
NCT05215366 ·Status: UNKNOWN
-
Open-Label Extension Study to Assess the Safety and Seizure Frequency Associated With Lacosamide for Primary Generalized Tonic-Clonic Seizures in Subjects With Epilepsy
NCT01118962 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy of Lacosamide as Additional Therapy in Patients Suffering From Epileptic Tonic-Clonic Seizures
NCT02408549 ·Status: COMPLETED ·Phase: PHASE3
-
An Observational Study of Epilepsy: Biology and Outcomes Using Real-world Data
NCT05632978 ·Status: RECRUITING
-
Study Of The Safety And Efficacy Of Lyrica In The Treatment Of Newly Diagnosed Partial Epilepsy
NCT00280059 ·Status: COMPLETED ·Phase: PHASE3
-
Novel Network Analysis of Intracranial Stereoelectroencephalography
NCT03916848 ·Status: UNKNOWN ·Phase: NA
-
Study of Specimens Obtained During Epilepsy Surgery
NCT00025714 ·Status: COMPLETED
-
Human Epilepsy Project 3
NCT05374928 ·Status: ACTIVE_NOT_RECRUITING
-
Cannabidiol Oral Solution in Pediatric Participants With Treatment-Resistant Childhood Absence Seizures
NCT03336242 ·Status: TERMINATED ·Phase: PHASE2
-
Microbiome Composition and Biomarker Discovery in Refractory Pediatric Epilepsy
NCT04311242 ·Status: WITHDRAWN
-
Therapeutic Drug Monitoring of New Generation Antiepileptic Drugs
NCT02739282 ·Status: COMPLETED ·Phase: NA
-
Evaluation and Treatment of Patients With Epilepsy
NCT00013845 ·Status: TERMINATED
-
Proof of Principle for a Diagnostic Blood Test of Recurrent Seizures
NCT02269397 ·Status: COMPLETED
-
Effects of Mega-dose Vitamin D Pulse and Maintenance Therapy on Seizure Frequency, Fatigue, and Quality of Life: A Prospective Study
NCT06736002 ·Status: RECRUITING ·Phase: NA
-
Expanded Access Use of Stiripentol in Dravet Syndrome or Sodium Channel Mutation Epileptic Encephalopathies
NCT02239276 ·Status: NO_LONGER_AVAILABLE
-
Targeting the Gut to Improve Seizure Control in CDKL5 Deficiency Disorder (CDD)
NCT06448663 ·Status: RECRUITING ·Phase: NA
-
A Pilot Study of the Low Glycaemic Index Diet in Adults With Epilepsy
NCT03999827 ·Status: COMPLETED ·Phase: NA
-
The Effect of Anti-epileptic Drugs on Mitochondrial Activity
NCT01218321 ·Status: COMPLETED